Scottish Firm Targets South Korea for Cancer Patch

Scottish company ProStrakan has landed a South Korean partner for its novel transdermal patch for chemotherapy-induced nausea, the firm’s first patch product with ambitions to steal a sizeable chunk of a €2bn market.
Outsourcing-Pharma.com